Recall
FDAHealthJune 24, 2026

Covidien, LP — Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623

⚠️ Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 24, 2026

US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan.

What's affected?

Product
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
Lot code
D6A2963Y

Additional details

SP-623 UDI-DI 20884521037073 Lot D6A2963Y

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 135,875 total.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.